Cotiviti, a healthcare data analytics company backed by KKR and Veritas Capital, is nearing a deal to acquire its rival, Edifecs, for approximately $3.05 billion. This decision comes as Edifecs' owners favor Cotiviti's bid over a higher $3.5 billion offer from UnitedHealth Group, primarily due to fewer antitrust concerns and a quicker transaction process.
Edifecs specializes in software solutions that streamline the sharing of administrative and clinical data across various sectors of the U.S. healthcare system, including payers, hospitals, employers, and government health agencies. In 2020, private equity firms TA Associates and Francisco Partners acquired a majority stake in Edifecs, valuing the company at $1.4 billion.
This potential acquisition highlights the impact of antitrust considerations on major U.S. corporations. UnitedHealth Group has faced extensive regulatory scrutiny in recent years, including lawsuits from the Department of Justice and the Federal Trade Commission, which likely influenced Edifecs' preference for Cotiviti's offer.
In May 2024, Cotiviti completed a recapitalization with KKR and its long-standing partner, Veritas Capital, positioning the company for continued growth and innovation in the healthcare sector.
#Cotiviti #Edifecs #HealthcareData #KKR #VeritasCapital #HealthcareInnovation #MergersAndAcquisitions #HealthTech #DataAnalytics #HealthcareTransformation #BusinessDeal #TechNews
Edifecs specializes in software solutions that streamline the sharing of administrative and clinical data across various sectors of the U.S. healthcare system, including payers, hospitals, employers, and government health agencies. In 2020, private equity firms TA Associates and Francisco Partners acquired a majority stake in Edifecs, valuing the company at $1.4 billion.
This potential acquisition highlights the impact of antitrust considerations on major U.S. corporations. UnitedHealth Group has faced extensive regulatory scrutiny in recent years, including lawsuits from the Department of Justice and the Federal Trade Commission, which likely influenced Edifecs' preference for Cotiviti's offer.
In May 2024, Cotiviti completed a recapitalization with KKR and its long-standing partner, Veritas Capital, positioning the company for continued growth and innovation in the healthcare sector.
#Cotiviti #Edifecs #HealthcareData #KKR #VeritasCapital #HealthcareInnovation #MergersAndAcquisitions #HealthTech #DataAnalytics #HealthcareTransformation #BusinessDeal #TechNews
Cotiviti, a healthcare data analytics company backed by KKR and Veritas Capital, is nearing a deal to acquire its rival, Edifecs, for approximately $3.05 billion. This decision comes as Edifecs' owners favor Cotiviti's bid over a higher $3.5 billion offer from UnitedHealth Group, primarily due to fewer antitrust concerns and a quicker transaction process.
Edifecs specializes in software solutions that streamline the sharing of administrative and clinical data across various sectors of the U.S. healthcare system, including payers, hospitals, employers, and government health agencies. In 2020, private equity firms TA Associates and Francisco Partners acquired a majority stake in Edifecs, valuing the company at $1.4 billion.
This potential acquisition highlights the impact of antitrust considerations on major U.S. corporations. UnitedHealth Group has faced extensive regulatory scrutiny in recent years, including lawsuits from the Department of Justice and the Federal Trade Commission, which likely influenced Edifecs' preference for Cotiviti's offer.
In May 2024, Cotiviti completed a recapitalization with KKR and its long-standing partner, Veritas Capital, positioning the company for continued growth and innovation in the healthcare sector.
#Cotiviti #Edifecs #HealthcareData #KKR #VeritasCapital #HealthcareInnovation #MergersAndAcquisitions #HealthTech #DataAnalytics #HealthcareTransformation #BusinessDeal #TechNews
